Our company’s inception dates back to the early 2000’s, when we tragically lost a family member who contracted MRSA during their hospital stay following surgery, and succumbed to the infection. Motivated by this devastating experience, our dedicated team with a collective experience of over 20 years in healthcare and sensitive environments, embarked on a quest to address the alarming statistics surrounding hospital-acquired infections.

In 2012, the Vytis Shield research team initiated extensive research aimed at developing groundbreaking technology to bridge the gaps in infection prevention within healthcare facilities nationwide. Through meticulous observation and data collection, we identified the key areas where microbe transmission occurs, particularly high touch surfaces and objects in constant movement, such as medicine carts, hospital beds, and food carts. Our goal was to create a non-disruptive system that could effectively target these areas and minimize the risk of contamination.

Based on real-world data obtained from hospitals, our innovative approach has demonstrated a remarkable 99.13% residual reduction in microbes, lasting up to 12 months on treated surfaces. Additionally, we have successfully formulated an FDA registered hand-sanitizer with a proven track record of eliminating 99.99% of germs for up to 12 hours.

Vytis Shield is dedicated to transforming infection control, through our exclusive, patented medical technology. Our primary objective is to significantly diminish the occurrence of hospital-acquired infections, all while ensuring minimal disruption to hospital protocols without a need for staff re-training. Our ultimate aim is to spare families from the devastating loss of their loved ones due to preventable infections.